Protective Vaccine Against Staphylococcus Aureus Biofilms Comprising Cell Wall-associated Immunogens

Vaccine formulations effective against Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA) are disclosed, as well as methods of using the vaccine formulations in the treatment, prevention and prophylaxis of Staphylococcus aureus infections in a subject.

Patents:
WO 2,010,039,563

Inventor(s): SHIRTLIFF MARK E [US]; O'MAY GRAEME [US]; LEID JEFF [US]

Type of Offer: Licensing



Next Patent »
« More Pharmaceutical Patents

Share on      


CrowdSell Your Patent